Functional and dysfunctional impulsivities changes after deep brain stimulation of the subthalamic nucleus
Objective: We investigated changes of impulsivity after deep brain stimulation (DBS) of the subthalamic nucleus (STN) in Parkinson’s disease (PD) patients, distinguishing functional from dysfunctional…Directional leads in deep brain stimulation – surgical handling and evolving therapy options
Objective: To analyse the objective data and experiences in the application of directional leads (D-leads) in deep brain stimulation (DBS) for movement disorders. Background: Recent…Online determination of the STN “sweet spot” based on beta-power measured with directional macro-contacts of the final DBS lead
Objective: Microelectrode recordings are the standard procedure for intraoperative, electrophysiological mapping of the STN[1]. We investigated a novel methodology to detect the STN sweet spot…Directional deep brain stimulation: what’s for?
Objective: to characterize the therapeutic window of ring and directional stimulation in subjects with PD and DBS of the subthalamic nucleus (STN) or the Globus…“Poised for Parkinson’s”: Group classes in Alexander technique for managing symptoms of Parkinson’s disease
Objective: To develop and test a group course using Alexander technique (AT) principles to improve functional mobility and quality of life for people living with…The spectrum of involuntary vocalizations in humans
Objective: To provide a detailed overview of the wide spectrum of involuntary vocalizations in humans, their etiologies and treatment recommendations. Background: Abnormal vocalizing behaviors are…Assessment, identification and classification of movement disorders in 22q11.2 deletion syndrome
Objective: To assess the nature and frequency of movement disorders in children with molecularly confirmed 22q11.2 Deletion Syndrome. Background: 22q11.2 Deletion Syndrome (22q11.2DS) is a…The Role of Environmental Toxins (Rotenone) in Parkinson’s Disease
Objective: Learn the role of environmental toxins - rotenone in development of Parkinson's disease Background: Rotenone is a powerful pesticide. It is also a lipophilic…The Relationship of Neuropsychiatric Symptoms and Cognitive Impairment in Parkinson’s Disease
Objective: To assess the relationship between individual items from the Neuropsychiatric Inventory and five cognitive domains in patients with Parkinson's disease (PD) and normal cognitive…The Influence of Sociodemographic Factors on Post-DBS Impulse Control Symptom Severity in Parkinson’s Disease
Objective: To develop a model to predict changes in impulse control symptom severity (ICSS) following deep brain stimulation (DBS) in patients with Parkinson’s disease (PD).…
- « Previous Page
- 1
- …
- 128
- 129
- 130
- 131
- 132
- …
- 217
- Next Page »